Beena Goldenberg

Large global tobacco companies are investing in and partnering with cannabis companies with eyes set on future growth for the sector. Industry experts shared the reasons why the cannabis sector is attractive to tobacco companies during the 2025 Benzinga Cannabis Capital Conference in Chicago....

Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), Canada’s leading cannabis company by market share, has announced that CEO Beena Goldenberg will retire at the end of the company's fiscal year, September 30, 2025. Goldenberg, who joined Organigram as CEO in September 2021, will remain in her...

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) announced the acquisition of 100% of Motif Labs Ltd. for CA$90 million ($64 million), comprising of CA$50 million in cash and CA$40 million in Organigram common shares, based on a 30-day trading VWAP of $2.321 on the TSX. An additional CA$10 million...

In a global cannabis market brimming with potential, where should businesses focus their attention? Experts from the Benzinga Cannabis Capital Conference examined the profitability and growth prospects across Europe, Australia, Southeast Asia, and Canada, with Germany standing out as the market...

Cannabis producer Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) announced its financial results on Tuesday for the third quarter ended June 30, 2024, revealing net revenue increased 25% year-over-year to CA$41.1 million ($29.9 million). Beena Goldenberg, the company's CEO, praised the revenue...

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) announced on Tuesday a strategic investment aimed at expanding its presence within the burgeoning European cannabis market. What Happened The Toronto-based company will utilize proceeds from its Jupiter strategic investment pool and invest €14 million...

Canadian cannabis company Organigram Holdings Inc.(NASDAQ:OGI) (TSX:OGI) reported its financial results Tuesday for the second quarter that ended March 31, 2024, revealing net revenue of CA$37.63 million ($27.53 million), compared to CA$39.5 million in the same period of last year.  "We are pleased...

The Canadian government unveiled its 2024 budget on Tuesday and there was no excise tax relief for cannabis companies the industry was hoping for.  In February, the House of Commons Standing Committee on Finance recommended limiting the excise tax rate to 10%, igniting optimism across the cannabis...

Cannabis producer Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) announced its first quarter financial results on Tuesday for the three months ended Dec. 31, 2023. The Toronto-based company reported a 16% year-over-year decrease in net revenue to CA$36.5 million ($27.1 million), attributing it to...

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) reported on Tuesday its fourth quarter financial results for the three months ended Sept. 30., revealing an 11% year-over-year increase in net revenue to CA$161.6 million ($120.7 million). Moreover, the Canadian producer reported a 71% increase in...

Canadian cannabis company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced on Monday a CA$124.6 million ($91.2 million) follow-on strategic equity investment from BT DE Investments Inc., a wholly-owned subsidiary of tobacco giant British American Tobacco p.l.c (BAT) (LSE: BATS) (NYSE:...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has expanded its global footprint by entering into a supply agreement to provide dried medical cannabis flower to 4C LABS, a healthcare, technology, and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution, and clinical...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) has entered into a supply agreement for dried flower with the medical division of German cannabis company Sanity Group. Through exports from its cultivation facility in Moncton, Organigram already services medical patients in Israel and Australia,...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) net revenue in Q2 fiscal 2023 increased 24% to CA$39.5 million ($29.3 million), from CA$31.8 million in Q2 fiscal 2022. The increase was primarily due to an increase in international revenue, partly offset by a decrease in medical sales. Q2 FY 2023...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) has entered into a product purchase agreement with Green Tank Technologies Corp. and a subscription agreement with Greentank’s parent company, Weekend Holdings Corp. The purchase agreement provides Organigram with an exclusivity period in...